{"id":"https://genegraph.clinicalgenome.org/r/0c23cf76-f090-4b9c-9de3-272a86f919f4v1.0","type":"EvidenceStrengthAssertion","dc:description":"*GATA4* was first reported in relation to autosomal dominant Structural congenital heart disease, multiple types - *GATA4* in 2003 (Garg et al., PMID:12845333). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanisms, inheritance pattern and phenotypic variability. Therefore, the following disease entities have been lumped into one disease entity: Atrial Septal Defect 2 (OMIM:607941), Atrioventricular Septal Defect 4 (OMIM: 614430), Tetralogy of Fallot (OMIM: 187500), Ventricular Septal Defect 1 (OMIM:614429). Sixteen unique variants (missense, nonsense, frameshift) that have been reported in sixteen probands in seven publications (PMIDs: 15810002, 12845333, 22101736, 18672102, 24000169, 29377543, 28991257) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is also supported by two mouse models, expression data, and functional alteration data (PMIDs: 17643447, 15310850, 31322241, 31322241). In summary, *GATA4* is definitively associated with autosomal dominant Structural congenital heart disease, multiple types - *GATA4*. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 2/7/2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/0c23cf76-f090-4b9c-9de3-272a86f919f4","GCISnapshot":"https://genegraph.clinicalgenome.org/r/005cf235-4d8d-4f12-9e75-59d3f7c4d933","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/005cf235-4d8d-4f12-9e75-59d3f7c4d933_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2023-04-18T17:53:21.654Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/005cf235-4d8d-4f12-9e75-59d3f7c4d933_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2023-02-07T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/005cf235-4d8d-4f12-9e75-59d3f7c4d933_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bad80bd-290b-4c67-8455-0adbd88c23f9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bad80bd-290b-4c67-8455-0adbd88c23f9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18672102","allele":{"id":"https://genegraph.clinicalgenome.org/r/f1ea4968-7154-41dd-a505-2a2f8a808090","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.17C>T (p.Ala6Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4630590"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/eb85715b-2a11-47ba-a6d2-ffbb7ebfbc47","type":"EvidenceLine","dc:description":"Recurrent variant","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb85715b-2a11-47ba-a6d2-ffbb7ebfbc47_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15810002","allele":{"id":"https://genegraph.clinicalgenome.org/r/0f2d55df-7388-493d-9f51-22fcca6ee04c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.1078del (p.Glu360ArgfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913184949"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/91649958-681e-4ff8-930b-276a5ccf67cc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91649958-681e-4ff8-930b-276a5ccf67cc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Immunoblot of total cell lysate in HeLa cells showed less transcriptional activation of Myhc and ANF enhancers compared to wild type","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/91649958-681e-4ff8-930b-276a5ccf67cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12845333","allele":{"id":"https://genegraph.clinicalgenome.org/r/e3cf616b-b3b2-4fd5-914c-39f6a0d8518f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.889G>A (p.Gly297Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212661"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/27deb158-cdc1-496b-8cd6-264fd2d66f1e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/27deb158-cdc1-496b-8cd6-264fd2d66f1e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15810002","allele":{"id":"https://genegraph.clinicalgenome.org/r/7224b76c-3acb-4629-9241-ceea628e87c7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.155C>T (p.Ser52Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212662"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9a5d8df4-12e0-4ac5-af8a-3063a8f025ca","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a5d8df4-12e0-4ac5-af8a-3063a8f025ca_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Immunoblot of total cell lysate in HeLa cells showed less transcriptional activation of Myhc and ANF enhancers compared to wild type","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9a5d8df4-12e0-4ac5-af8a-3063a8f025ca_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12845333","allele":{"id":"https://genegraph.clinicalgenome.org/r/0f2d55df-7388-493d-9f51-22fcca6ee04c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d00cd793-dfd0-4fd6-81a5-85fab16990a0","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d00cd793-dfd0-4fd6-81a5-85fab16990a0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18672102","allele":{"id":"https://genegraph.clinicalgenome.org/r/995f96ba-3613-4090-9a60-03e6cd83bbcc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.118_119insA (p.Pro40HisfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2579825329"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0f82d9fd-c75e-4fdd-8d4e-7b5b989cf33d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f82d9fd-c75e-4fdd-8d4e-7b5b989cf33d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28991257","allele":{"id":"https://genegraph.clinicalgenome.org/r/76166e12-b3e5-4c80-9140-ba38b3620ff3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.1283G>A (p.Trp428Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370315797"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e08e0210-8eec-4552-bc83-d5d4252f9270","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e08e0210-8eec-4552-bc83-d5d4252f9270_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28991257","allele":{"id":"https://genegraph.clinicalgenome.org/r/d47bbcc1-5d57-496b-8786-310ad7c3bcc0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.1237del (p.Ser413LeufsTer28)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2579823151"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/005cf235-4d8d-4f12-9e75-59d3f7c4d933_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73fc0ff9-d8c7-4630-986c-f61b1f3b5fa1_proband_segregation","type":"FamilyCosegregation","dc:description":"Whole-genome linkage analysis was performed ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12845333","rdfs:label":"Family B","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/73fc0ff9-d8c7-4630-986c-f61b1f3b5fa1","type":"Family","rdfs:label":"Family B","member":{"id":"https://genegraph.clinicalgenome.org/r/497d3ef8-1b1c-42db-8143-b78a44722486","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12845333","rdfs:label":"Proband IV.1","allele":{"id":"https://genegraph.clinicalgenome.org/r/0f2d55df-7388-493d-9f51-22fcca6ee04c"},"detectionMethod":"Direct sequencing of GATA4. The third or fifth exon of the human GATA4 gene was amplified by PCR and the PCR product was sequenced in both directions.","firstTestingMethod":"PCR","phenotypes":"obo:HP_0001631","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9a5d8df4-12e0-4ac5-af8a-3063a8f025ca_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":"obo:HP_0001631","proband":{"id":"https://genegraph.clinicalgenome.org/r/497d3ef8-1b1c-42db-8143-b78a44722486"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/28c42170-a00c-48b1-9c53-4eea88bb613f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24000169","rdfs:label":"Yang Family 1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/28c42170-a00c-48b1-9c53-4eea88bb613f","type":"Family","rdfs:label":"Yang Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/e388a112-09e6-45fd-8b02-4f41a0712fea","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24000169","rdfs:label":"Yang Proband III-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":16,"allele":{"id":"https://genegraph.clinicalgenome.org/r/4dcdd085-6551-4390-bfa9-920733b5401e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.25G>C (p.Ala9Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370308504"}},"detectionMethod":"Direct sequencing of GATA4 coding regions and splice junctions","firstTestingMethod":"PCR","phenotypes":["obo:HP_0005110","obo:HP_0001636"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3fd1f830-963a-40f6-84d2-03a115840ab2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24000169","allele":{"id":"https://genegraph.clinicalgenome.org/r/4dcdd085-6551-4390-bfa9-920733b5401e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0001636","proband":{"id":"https://genegraph.clinicalgenome.org/r/e388a112-09e6-45fd-8b02-4f41a0712fea"}},{"id":"https://genegraph.clinicalgenome.org/r/51bce3c8-9ae6-4b1d-bda5-6e2fae0641ff_proband_segregation","type":"FamilyCosegregation","dc:description":"Exons and flanking introns of GATA4, NKX2.5, TBX5, ANP, and Cx40 were amplified using PCR and directly sequenced in both direction.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15810002","rdfs:label":"Family 1","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/51bce3c8-9ae6-4b1d-bda5-6e2fae0641ff","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/59b66b87-fd89-4d58-b6cb-603f5a7edc2f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15810002","rdfs:label":"Proband II-3","allele":{"id":"https://genegraph.clinicalgenome.org/r/0f2d55df-7388-493d-9f51-22fcca6ee04c"},"detectionMethod":"Exons and flanking introns of GATA4, NKX2.5, TBX5, ANP, and Cx40 were amplified using PCR and directly sequenced in both direction.","firstTestingMethod":"PCR","phenotypes":"obo:HP_0001684","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/eb85715b-2a11-47ba-a6d2-ffbb7ebfbc47_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":"obo:HP_0001684","proband":{"id":"https://genegraph.clinicalgenome.org/r/59b66b87-fd89-4d58-b6cb-603f5a7edc2f"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/cc488d63-be0f-46cf-a119-1e1e2e4d8d82_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24000169","rdfs:label":"Yang Family 2","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/cc488d63-be0f-46cf-a119-1e1e2e4d8d82","type":"Family","rdfs:label":"Yang Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/685b6212-08fe-4c8a-ad2f-0086893d2500","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24000169","rdfs:label":"Yang Proband III-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f2c22695-8f99-4151-bcac-1b1eda414782","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.151C>G (p.Leu51Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370309009"}},"detectionMethod":"Direct sequencing of GATA4 coding regions and splice junctions","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001636","obo:HP_0001631"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/77910885-1083-4f7a-808c-2ab9e769faf3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24000169","allele":{"id":"https://genegraph.clinicalgenome.org/r/f2c22695-8f99-4151-bcac-1b1eda414782"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001631","obo:HP_0001636"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/685b6212-08fe-4c8a-ad2f-0086893d2500"}},{"id":"https://genegraph.clinicalgenome.org/r/b64b93e1-01b2-42b8-997d-d0bb4b2b7fb4_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15810002","rdfs:label":"Family 2","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/b64b93e1-01b2-42b8-997d-d0bb4b2b7fb4","type":"Family","rdfs:label":"Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/950c8a63-93d9-4fa3-a3d5-109ced5f88db","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15810002","rdfs:label":"Proband II-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/7224b76c-3acb-4629-9241-ceea628e87c7"},"detectionMethod":"Exons and flanking introns of GATA4, NKX2.5, TBX5, ANP, and Cx40 were amplified using PCR and directly sequenced in both direction.","firstTestingMethod":"PCR","phenotypes":"obo:HP_0001631","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/27deb158-cdc1-496b-8cd6-264fd2d66f1e_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0001631","proband":{"id":"https://genegraph.clinicalgenome.org/r/950c8a63-93d9-4fa3-a3d5-109ced5f88db"}},{"id":"https://genegraph.clinicalgenome.org/r/b77f7d32-34e9-4051-a883-7765a0b8d469_proband_segregation","type":"FamilyCosegregation","dc:description":"Performed a genome-wide scan of all family members that revealed linkage of the CHD phenotype to a single locus on chromosome 8p22-23 ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12845333","rdfs:label":"Family A","estimatedLodScore":3.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/b77f7d32-34e9-4051-a883-7765a0b8d469","type":"Family","rdfs:label":"Family A","member":{"id":"https://genegraph.clinicalgenome.org/r/aedf1779-9bab-4d04-971b-b209d12a3fd6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12845333","rdfs:label":"Proband V.7","allele":{"id":"https://genegraph.clinicalgenome.org/r/e3cf616b-b3b2-4fd5-914c-39f6a0d8518f"},"phenotypes":["obo:HP_0001631","obo:HP_0001642","obo:HP_0001629"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/91649958-681e-4ff8-930b-276a5ccf67cc_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":12,"phenotypes":["obo:HP_0001629","obo:HP_0001631","obo:HP_0001642"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/aedf1779-9bab-4d04-971b-b209d12a3fd6"},"publishedLodScore":5.7,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/3c7721f3-e768-4d89-b090-facfed4066e4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24000169","rdfs:label":"Yang Family 3","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/3c7721f3-e768-4d89-b090-facfed4066e4","type":"Family","rdfs:label":"Yang Family 3","member":{"id":"https://genegraph.clinicalgenome.org/r/77397d18-9326-4e2a-b9e3-af707ad0cdb8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24000169","rdfs:label":"Yang Proband III-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/daf039a5-06fd-4d28-b802-12d95f4d129e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.857A>G (p.Asn286Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370313042"}},"detectionMethod":"Direct sequencing of GATA4 coding regions and splice junctions","firstTestingMethod":"PCR","phenotypes":"obo:HP_0001636","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/04c0b8ed-c819-4b79-b626-5d5ba33b0882_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24000169","allele":{"id":"https://genegraph.clinicalgenome.org/r/daf039a5-06fd-4d28-b802-12d95f4d129e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0001636","proband":{"id":"https://genegraph.clinicalgenome.org/r/77397d18-9326-4e2a-b9e3-af707ad0cdb8"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/0f06daef-a714-4345-ae02-cc626c3c252d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f06daef-a714-4345-ae02-cc626c3c252d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18672102","allele":{"id":"https://genegraph.clinicalgenome.org/r/1908dde2-c293-4120-b49f-8a556a75f735","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.1289G>C (p.Ser430Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370315813"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/04c0b8ed-c819-4b79-b626-5d5ba33b0882","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04c0b8ed-c819-4b79-b626-5d5ba33b0882_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"EMSA in HEK293 cells showed drastically diminished DNA-binding affinity of the mutant GATA4 proteins compared to wild-type","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/04c0b8ed-c819-4b79-b626-5d5ba33b0882_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1bcd0d57-bed6-4522-93e6-33852e6b4a84","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bcd0d57-bed6-4522-93e6-33852e6b4a84_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18672102","allele":{"id":"https://genegraph.clinicalgenome.org/r/8bf34690-8f74-4f76-8b30-4c5de1c5e83f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.47del (p.Gly16ValfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2579827863"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/70791ac5-2587-471e-b943-0300a40e297b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70791ac5-2587-471e-b943-0300a40e297b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18672102","allele":{"id":"https://genegraph.clinicalgenome.org/r/e95acd30-38e6-4d19-ae35-fcfc45eb0082","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.125_126insAA (p.Arg43SerfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2579828094"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/77910885-1083-4f7a-808c-2ab9e769faf3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77910885-1083-4f7a-808c-2ab9e769faf3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"EMSA in HEK293 cells showed slightly diminished DNA-binding affinity of the mutant GATA4 proteins compared to wild-type","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/77910885-1083-4f7a-808c-2ab9e769faf3_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5b4f442c-35c5-4a4e-824f-c13bbb288761","type":"EvidenceLine","dc:description":"gnomAd frequency was higher than 0.00001","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b4f442c-35c5-4a4e-824f-c13bbb288761_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29377543","allele":{"id":"https://genegraph.clinicalgenome.org/r/629fe6de-305f-4a62-8bf8-966e78d7b714","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.821A>G (p.Asn274Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370312967"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3fd1f830-963a-40f6-84d2-03a115840ab2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fd1f830-963a-40f6-84d2-03a115840ab2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"EMSA in HEK293 cells showed slightly diminished DNA-binding affinity of the mutant GATA4 proteins compared to wild-type","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3fd1f830-963a-40f6-84d2-03a115840ab2_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bc050ca1-845b-423e-a72a-273a875c4efb","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc050ca1-845b-423e-a72a-273a875c4efb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29377543","allele":{"id":"https://genegraph.clinicalgenome.org/r/18f2bf22-57c5-47b8-90c1-51545c9542d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001308093.3(GATA4):c.884C>T (p.Ala295Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370313104"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/005cf235-4d8d-4f12-9e75-59d3f7c4d933_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/005cf235-4d8d-4f12-9e75-59d3f7c4d933_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2af48cd8-7491-4740-8e72-59c540464793","type":"EvidenceLine","dc:description":"Downgraded for being a null model that does not replicate the exact phenotypes","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc1da11d-b5e5-46d0-b35a-2bf8d92d17f9","type":"Finding","dc:description":"The model demonstrates a requirement for GATA4 during early cardiac development and identify an essential factor for generation of the proepicardium. Gata4-null mouse embryos displayed heart defects characterized by disrupted looping morphogenesis, septation, and a hypoplastic ventricular myocardium. \nThe proepicardium was absent in Gata4-null embryos, blocking formation of the epicardium","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15310850","rdfs:label":"Null mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ca2f36fd-bbb8-4890-9f8c-b6d961746f1e","type":"EvidenceLine","dc:description":"The model matches the genotype and the phenotype of CHD patients with autosomal dominant GATA4 variants","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/229c1419-3a66-4ea1-a245-30ff7b7b1edb","type":"Finding","dc:description":"G4D mice heterozygous for a Gata4 mutation showed ASD, VSD, AVSD, right ventricular hypoplasia, and cardiomyopathy which are similar to structural heart defects in human CHD patients with GATA4 variants","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17643447","rdfs:label":"Murine model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/005cf235-4d8d-4f12-9e75-59d3f7c4d933_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89f9e999-66f2-477b-b5e9-cccf426966e7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/337a64de-d65a-4fcf-9b29-351d36f97dd7","type":"FunctionalAlteration","dc:description":"EMSA using wild-type and mutant GATA4 (p.H436Y) proteins from transfected HeLa cells, with a biotin-labeled probe showed that the mutant GATA4 protein decreased the ability to bind the conserved GATA-binding site on the HAND2 gene, which may contribute to abnormal expression of the HAND2 gene","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31322241","rdfs:label":"EMSA in HeLa cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/005cf235-4d8d-4f12-9e75-59d3f7c4d933_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc58ea0d-12e5-4cb7-9271-975c9e8d10f9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2affe3cc-c9ec-4230-b50e-43428ab3ff62","type":"Finding","dc:description":"RT-qPCR performed following extraction of total RNA from HeLa cells revealed that the mRNA expression levels of GATA4 were significantly lower in the mutant group compared with the wild-type group. Western blot analysis demonstrated that the GATA4 mutation significantly reduced GATA4 protein expression ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31322241","rdfs:label":"Expression in HeLa cells","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":6155,"specifiedBy":"GeneValidityCriteria9","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/LmQqjzfV1zo","type":"GeneValidityProposition","disease":"obo:MONDO_0100009","gene":"hgnc:4173","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_005cf235-4d8d-4f12-9e75-59d3f7c4d933-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}